Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ksenya Cohen Katsenelson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annual Review of Pharmacology and Toxicology|September 30, 2020
PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell SignalingTimothy R Baffi, Ksenya Cohen-Katsenelson, Alexandra C Newton
The Biochemical Journal|July 14, 2011
Docking interactions of the JNK scaffold protein WDR62Ksenya Cohen-Katsenelson, Tanya Wasserman, Samer Khateb, et al.
The Journal of Biological Chemistry|January 24, 2013
Identification and analysis of a novel dimerization domain shared by various members of c-Jun N-terminal kinase (JNK) scaffold proteinsKsenya Cohen-Katsenelson, Tanya Wasserman, Ilona Darlyuk-Saadon, et al.
Elife|August 14, 2019
PHLPP1 counter-regulates STAT1-mediated inflammatory signalingKsenya Cohen Katsenelson, Joshua D Stender, Agnieszka T Kawashima, et al.
American Journal of Medical Genetics. Part A|August 7, 2013
Infantile mitochondrial hepatopathy is a cardinal feature of MEGDEL syndrome (3-methylglutaconic aciduria type IV with sensorineural deafness, encephalopathy and Leigh-like syndrome) caused by novel mutations in SERAC1Ofer Sarig, Dorit Goldsher, Janna Nousbeck, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2014
Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase outputGloria Reyes, Matt Niederst, Ksenya Cohen-Katsenelson, et al.
American Journal of Human Genetics|July 31, 2012
Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis syndrome is caused by a POC1A mutationOfer Sarig, Sagi Nahum, Debora Rapaport, et al.
The Journal of Cell Biology|May 17, 2019
The PHLPP2 phosphatase is a druggable driver of prostate cancer progressionDawid G Nowak, Ksenya Cohen Katsenelson, Kaitlin E Watrud, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annual Review of Pharmacology and Toxicology|September 30, 2020
PHLPPing the Script: Emerging Roles of PHLPP Phosphatases in Cell SignalingTimothy R Baffi, Ksenya Cohen-Katsenelson, Alexandra C Newton
The Biochemical Journal|July 14, 2011
Docking interactions of the JNK scaffold protein WDR62Ksenya Cohen-Katsenelson, Tanya Wasserman, Samer Khateb, et al.
The Journal of Biological Chemistry|January 24, 2013
Identification and analysis of a novel dimerization domain shared by various members of c-Jun N-terminal kinase (JNK) scaffold proteinsKsenya Cohen-Katsenelson, Tanya Wasserman, Ilona Darlyuk-Saadon, et al.
Elife|August 14, 2019
PHLPP1 counter-regulates STAT1-mediated inflammatory signalingKsenya Cohen Katsenelson, Joshua D Stender, Agnieszka T Kawashima, et al.
American Journal of Medical Genetics. Part A|August 7, 2013
Infantile mitochondrial hepatopathy is a cardinal feature of MEGDEL syndrome (3-methylglutaconic aciduria type IV with sensorineural deafness, encephalopathy and Leigh-like syndrome) caused by novel mutations in SERAC1Ofer Sarig, Dorit Goldsher, Janna Nousbeck, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 10, 2014
Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase outputGloria Reyes, Matt Niederst, Ksenya Cohen-Katsenelson, et al.
American Journal of Human Genetics|July 31, 2012
Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis syndrome is caused by a POC1A mutationOfer Sarig, Sagi Nahum, Debora Rapaport, et al.
The Journal of Cell Biology|May 17, 2019
The PHLPP2 phosphatase is a druggable driver of prostate cancer progressionDawid G Nowak, Ksenya Cohen Katsenelson, Kaitlin E Watrud, et al.
Pageof 1